From the Journals

Sharing drug paraphernalia alone didn’t transmit HCV


 

FROM THE JOURNAL OF INFECTIOUS DISEASES

Hepatitis C virus couldn’t be transmitted through shared drug preparation paraphernalia, but sharing paraphernalia was associated with sharing syringes nevertheless, according to researchers at Yale University, New Haven, Conn.

That makes sharing paraphernalia a “surrogate” for HCV transmission “resulting from sharing drugs,” the investigators said, but it should not be a primary focus of harm-reduction and education programs.

Photo of heroin, hypodermic needle, and spoon PaulPaladin/thinkstock
In their experiment, Robert Heimer, PhD, and his colleagues prepared syringes contaminated with HCV and attempted to replicate the conditions in which persons injecting drugs share packages of drugs, syringes, and paraphernalia.

“Water was introduced into the barrel of a contaminated ‘input’ syringe and expelled into a ‘cooker,’ and the water was drawn up into a ‘receptive’ syringe through a cotton filter,” the study authors explained. “The ‘input’ syringe, ‘cooker,’ and filter were rinsed with tissue culture medium and introduced into the microculture assay. The water drawn into the second syringe was combined with an equal volume of double-strength medium and introduced into the microculture assay” (J Infect Dis. 2017. doi: 10.1093/infdis/jix427).

The researchers tested syringes (with fixed or detachable needles), cookers, and filters (single or pooled). They were significantly more likely to recover HCV from detachable-needle syringes than from fixed-needle syringes. In the input syringes, they recovered no HCV from 70 fixed-needle syringes while they did recover HCV from 96 of 130 (73.8%) detachable-needle syringes. HCV passed to both types of syringes in the experiment’s receptive syringes but at a much higher rate for those with detachable needles than for those with fixed needles (93.8% vs. 45.7%, respectively).

No HCV was recovered from any of the cookers, regardless of syringe type. Some was recovered from filters, at higher rates with detachable needles than with fixed (27.1% vs. 1.4%).

“Money spent on ‘cookers’ and filters would be better spent on giving away more syringes,” Dr. Heimer and his coauthors concluded. “Because HCV and HIV transmission are more likely if the syringe has a detachable rather than a fixed needle, efforts should focus on providing more syringes with fixed needles.”

Recommended Reading

Hepatitis C is a pediatric disease now
MDedge Infectious Disease
Hexavalent hepatitis B vaccination mostly immunogenic 10 years later
MDedge Infectious Disease
Liver cancer risk lower after sustained response to DAAs
MDedge Infectious Disease
FDA approves new treatment for adults with HCV
MDedge Infectious Disease
FDA advisory panel backs safety of new hepatitis B vaccine for adults
MDedge Infectious Disease
FDA approves faster, pangenotypic cure for hep C virus
MDedge Infectious Disease
AAP recommends hepatitis B vaccine within 24 hours of birth for all infants
MDedge Infectious Disease
Light alcohol use did not affect liver fibrosis progression in HIV/HCV-coinfected women
MDedge Infectious Disease
Burden of HCV-induced cirrhosis expected to shift from men to women
MDedge Infectious Disease
Hepatitis C falls as barrier to heart transplantation
MDedge Infectious Disease